P53 : a candidate antioncogeneROSS, D. W.Archives of pathology & laboratory medicine (1976). 1990, Vol 114, Num 4, issn 0363-0153, p. 432Article

Le Gène p53 = The P53 geneCHOPIN, Dominique; CAPPELLEN, D; FRADVANYI, Francois et al.Progrès en urologie (Paris). 2005, Vol 15, Num 6, pp 1338-1343, issn 1166-7087, 6 p., SUP1Article

MicroRNA 203 Expression in Keratinocytes Is Dependent on Regulation of p53 Levels by E6MCKENNA, Declan J; MCDADE, Simon S; PATEL, Daksha et al.Journal of virology. 2010, Vol 84, Num 20, pp 10644-10652, issn 0022-538X, 9 p.Article

Complicating the complexity of p53YEE, Karen S; VOUSDEN, Karen H.Carcinogenesis (New York. Print). 2005, Vol 26, Num 8, pp 1317-1322, issn 0143-3334, 6 p.Article

The p53 story : layers of complexityBRAITHWAITE, Antony W; ROYDS, Janice A; JACKSON, Paul et al.Carcinogenesis (New York. Print). 2005, Vol 26, Num 7, pp 1161-1169, issn 0143-3334, 9 p.Article

Cul4A physically associates with MDM2 and participates in the proteolysis of p53NAG, Alo; BAGCHI, Srilata; RAYCHAUDHURI, Pradip et al.Cancer research (Baltimore). 2004, Vol 64, Num 22, pp 8152-8155, issn 0008-5472, 4 p.Article

Le rôle du gène p53 dans les tumeurs malignes humaines : une découverte majeure en cancérologie : Pathologie de l'artère carotide interne = The role of the p53 gene in the human malignant tumors: a major discoveries in cancerologySOUSSI, T.La Revue du praticien (Paris). 1993, Vol 43, Num 19, pp 2531-2535, issn 0035-2640Article

The properties of p53 proteins selected for the loss of suppression of transformationOLSON, D. C; LEVINE, A. J.Cell growth and differentiation. 1994, Vol 5, Num 1, pp 61-71, issn 1044-9523Article

p53 mutations in human cancersHOLLSTEIN, M; SIDRANSKY, D; VOGELSTEIN, B et al.Science (Washington, D.C.). 1991, Vol 253, Num 5015, pp 49-53, issn 0036-8075Article

KR-POK Interacts with p53 and Represses Its Ability to Activate Transcription of p21WAF1/CDKN1AJEON, Bu-Nam; KIM, Min-Kyeong; LEE, Kyung-Ryul et al.Cancer research (Chicago, Ill.). 2012, Vol 72, Num 5, pp 1137-1148, issn 0008-5472, 12 p.Article

Les gènes suppresseurs de tumeurs RB et P53 = RB and P53 tumor suppressor genesMAY, P.Bulletin du cancer. 1993, Vol 80, Num 8, pp 690-692, issn 0007-4551Conference Paper

Gène P53 : ses mutations sont responsables de la moitié de tous les cancers = Gene P53: his mutations are responsible of the half of cancerIGGO, R.Médecine et hygiène. 1994, Vol 52, Num 2028, pp 1333-1334, issn 0025-6749Article

p53 gene mutations in multiple myeloma are associated with advanced forms of malignancyNERI, A; BALDINI, L; TRECCA, D et al.Blood. 1993, Vol 81, Num 1, pp 128-135, issn 0006-4971Article

Cancer risk from germline P53 mutationsFREBOURG, T; FRIEND, S. H.The Journal of clinical investigation. 1992, Vol 90, Num 5, pp 1637-1641, issn 0021-9738Article

Human p53 gene localized to short arm of chromosome 17MILLER, C; MOHANDAS, T; WOLF, D et al.Nature (London). 1986, Vol 319, Num 6056, pp 783-784, issn 0028-0836Article

Anti-angiogenesis efficacy of the garlic ingredient alliin and antioxidants : Role of nitric oxide and p53MOUSA, Ahmed S; MOUSA, Shaker A.Nutrition and cancer. 2005, Vol 53, Num 1, pp 104-110, issn 0163-5581, 7 p.Article

P53 and mdm-2: interactions between tumor suppressor gene and oncogene productsPERRY, M. E; LEVINE, A. J.The Mount Sinai journal of medicine. 1994, Vol 61, Num 4, pp 291-299, issn 0027-2507Article

Multiple steps in carcinogenesis involving alterations of multiple tumor suppressor genesYOKOTA, J; SUGIMURA, T.The FASEB journal. 1993, Vol 7, Num 10, pp 920-925, issn 0892-6638, 1Article

Mutations of the p53 gene in myelodysplastic syndrome (MDS) and MDS-derived leukemiaSUGIMOTO, K; HIRANO, N; TOYOSHIMA, H et al.Blood. 1993, Vol 81, Num 11, pp 3022-3026, issn 0006-4971Article

EBNA3C Attenuates the Function of p53 through Interaction with Inhibitor of Growth Family Proteins 4 and 5SAHA, Abhik; BAMIDELE, Adebowale; MURAKAMI, Masanao et al.Journal of virology. 2011, Vol 85, Num 5, pp 2079-2088, issn 0022-538X, 10 p.Article

Daxx cooperates with the axin/HIPK2/p53 complex to induce cell deathQINXI LI; XUAN WANG; XIAOLING WU et al.Cancer research (Baltimore). 2007, Vol 67, Num 1, pp 66-74, issn 0008-5472, 9 p.Article

Dissecting functional roles of p53 N-terminal transactivation domains by microarray expression analysisOHKI, Rieko; KAWASE, Tatsuya; OHTA, Tsutomu et al.Cancer science. 2007, Vol 98, Num 2, pp 189-200, issn 1347-9032, 12 p.Article

Prognostic significance of Ki-67 and p53 immunoreactivity in cutaneous squamous cell carcinomasMANSOOR, A; MCKEE, P. H; SIMPSON, J. A et al.The American journal of dermatopathology. 1996, Vol 18, Num 4, pp 351-357, issn 0193-1091Conference Paper

Flow cytometric analysis of p53 expression during the cell cycleKUROSE, A; SASAKI, K; ISHIDA, Y et al.Oncology. 1995, Vol 52, Num 2, pp 123-127, issn 0030-2414Article

p53-independent apoptotic and necrotic cell deaths induced by adenovirus infection : suppression by E1B 19K and Bcl-2 proteinsSUBRAMANIAN, T; TARODI, B; CHINNADURAI, G et al.Cell growth and differentiation. 1995, Vol 6, Num 2, pp 131-137, issn 1044-9523Article